Pictet Asset Management (UK)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Pictet Asset Management (UK)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$315K	Buy	+4,382	New	+$322K	﹤0.01%	1400

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pictet Asset Management (UK)'s TARO Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021: 4,382 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #1400 among its holdings.

76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

Pictet Asset Management (UK) held 4,382 shares of Taro Pharmaceutical Industries Ltd. worth $315K as of Q2 2021.
Taro Pharmaceutical Industries Ltd. was a new Pictet Asset Management (UK) position in Q2 2021.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1400 holding.
76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.